Insider Transactions in Q4 2023 at Adicet Bio, Inc. (ACET)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 12
2023
|
Blake Aftab Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,933
-14.61%
|
$7,933
$1.35 P/Share
|
|
Oct 02
2023
|
Francesco Galimi SVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,093
-9.14%
|
$8,093
$1.37 P/Share
|
|
Oct 02
2023
|
Brian Nicholas Harvey Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,096
-8.36%
|
$7,096
$1.37 P/Share
|
|
Oct 02
2023
|
Don Healey Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,069
-13.62%
|
$9,069
$1.37 P/Share
|
|
Oct 02
2023
|
Chen Schor President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,208
-13.11%
|
$23,208
$1.37 P/Share
|
|
Oct 02
2023
|
Chen Schor President & CEO |
BUY
Open market or private purchase
|
Indirect |
5,500
+11.23%
|
$5,500
$1.33 P/Share
|